Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 2
2010 5
2011 2
2013 4
2014 4
2015 5
2016 6
2017 3
2018 3
2019 5
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
The Roles of MicroRNA in Lung Cancer.
Wu KL, Tsai YM, Lien CT, Kuo PL, Hung AJ. Wu KL, et al. Among authors: Tsai YM. Int J Mol Sci. 2019 Mar 31;20(7):1611. doi: 10.3390/ijms20071611. Int J Mol Sci. 2019. PMID: 30935143 Free PMC article. Review.
Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis.
Hsu YL, Hung JY, Lee YL, Chen FW, Chang KF, Chang WA, Tsai YM, Chong IW, Kuo PL. Hsu YL, et al. Among authors: Tsai YM. Oncotarget. 2017 Sep 18;8(62):104831-104854. doi: 10.18632/oncotarget.21022. eCollection 2017 Dec 1. Oncotarget. 2017. PMID: 29285217 Free PMC article.
Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.
Hsu YL, Hung JY, Chiang SY, Jian SF, Wu CY, Lin YS, Tsai YM, Chou SH, Tsai MJ, Kuo PL. Hsu YL, et al. Among authors: Tsai YM, Tsai MJ. Oncotarget. 2016 May 10;7(19):27584-98. doi: 10.18632/oncotarget.8488. Oncotarget. 2016. PMID: 27050278 Free PMC article.
The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations.
Yang CJ, Tsai MJ, Hung JY, Lee MH, Tsai YM, Tsai YC, Hsu JF, Liu TC, Huang MS, Chong IW. Yang CJ, et al. Among authors: Tsai MJ, Tsai YM, Tsai YC. BMC Pharmacol Toxicol. 2017 Dec 13;18(1):82. doi: 10.1186/s40360-017-0190-1. BMC Pharmacol Toxicol. 2017. PMID: 29237484 Free PMC article.
36 results
Jump to page
Feedback